The roles and mechanisms of hypoxia in liver fibrosis

Liver fibrosis occurs in response to any etiology of chronic liver injury. Lack of appropriate clinical intervention will lead to liver cirrhosis or hepatocellular carcinoma (HCC), seriously affecting the quality of life of patients, but the current clinical treatments of liver fibrosis have not been developed yet. Recent studies have shown that hypoxia is a key factor promoting the progression of liver fibrosis. Hypoxia can cause liver fibrosis. Liver fibrosis can, in turn, profoundly further deepen the degree of hypoxia. Therefore, exploring the role of hypoxia in liver fibrosis will help to further understand the process of liver fibrosis, and provide the theoretical basis for its diagnosis and treatment, which is of great significance to avoid further deterioration of liver diseases and protect the life and health of patients. This review highlights the recent advances in cellular and molecular mechanisms of hypoxia in developments of liver fibrosis.

Abstract licence: CC BY-NC-ND

1. 33.

   The Effect of Inflammatory Cytokines in Alcoholic Liver Disease · 2013

2. 64.

   Activation of PPARγ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence · 2016

3. 76.

   Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective · 2018

4. 80.

   Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors · 2018

5. 89.

   TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019 · 2019

6. 90.

   Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis · 2019

94 more references, whose wording the paper’s licence keeps private.

• Macrophages in organ fibrosis: from pathogenesis to therapeutic targets · 2024

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.